Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: D

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
D'Almeida, H.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Daar, E. S.
K-5   COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US
Dahan, E.
P3-3   TREATMENT PREFERENCES DERIVED USING ADAPTIVE BEST-WORST CONJOINT (ABC) ANALYSIS,
P3-35   IMPACT OF A NOVEL METHOD OF PATIENT PREFERENCE ELICITATION ON DECISION QUALITY IN MEN WITH PROSTATE CANCER: PILOT DATA
Dai, T.
L-4   THE WELFARE CONSEQUENCES OF THE DONOR PRIORITY RULE
Dale, W.
P4-30   ILLOGICAL RESPONSES FOR JOINT HEALTH STATE UTILITIES; A COMPARISON OF TIME-TRADEOFFS AND STANDARD GAMBLE METHODS
Danahey, K.
P1-37   CREATION OF A GENOMIC PRESCRIBING SYSTEM FOR DELIVERY OF PHARMACOGENOMIC RESULTS AND PERSONALIZED PRESCRIPTION DECISION-MAKING
Dang, C. T.
P3-41   DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?
Dann, R. A.
P2-6   TO INVEST OR NOT TO INVEST: A STAKEHOLDER-DRIVEN APPROACH TO EARLY CYCLE ECONOMIC EVALUATION OF DIAGNOSTIC TECHNOLOGIES
Das, S.
P1-37   CREATION OF A GENOMIC PRESCRIBING SYSTEM FOR DELIVERY OF PHARMACOGENOMIC RESULTS AND PERSONALIZED PRESCRIPTION DECISION-MAKING
Davidovitch, N.
TRA1-5   AN INFUENZA VACCINATION POLICY BASED ON A PREVIOUS YEAR'S ILLNESS
Davidson, K. W.
P1-13   COST-EFFECTIVENESS OF ENHANCED DEPRESSION CARE FOR PATIENTS WITH ACUTE CORONARY SYNDROME AND DEPRESSIVE SYMPTOMS: RESULTS OF THE COPES RANDOMIZED CONTROLLED TRIAL
Dawson, N. V.
P1-29   PHYSICIAN OVERUTILIZATION OF SLEEP STUDIES IN PREDICTING PATIENT IMPROVEMENT USING CPAP
de Bekker-Grob, E. W.
P1-52   RANDOM REGRET MINIMIZATION: A NEW DISCRETE CHOICE MODEL FOR HEALTH ECONOMICS,
P4-36   MEN'S PREFERENCES FOR PROSTATE CANCER SCREENING: A DISCRETE CHOICE EXPERIMENT
de Blasio, B. F.
P1-9   COST-EFFECTIVENESS OF ROTAVIRUS VACCICINATION IN A MIDDLE INCOME COUNTRY: A DYNAMIC MODELLING APPROACH
de Graaf, G.
P1-45   USING THE NET MONETARY BENEFIT FRAMEWORK FOR THE OPTIMAL DICHOTOMIZATION OF DIAGNOSTIC TESTS: A CASE STUDY OF A DYSGLYCEMIA SCREENING PROGRAM,
P2-57   USING STOCHASTIC MULTI-CRITERIA ACCEPTABILITY ANALYSIS TO SUPPORT DECISION MAKING ON THE REIMBURSEMENT OF MEDICAL INTERVENTIONS
de Kwaadsteniet, E. W.
P4-33   EXPLICIT ATTITUDES SEEM MORE DECISIVE FOR INTENTIONS ABOUT CERVICAL CANCER SCREENING THAN IMPLICIT ATTITUDES
de Vries, M.
P4-33   EXPLICIT ATTITUDES SEEM MORE DECISIVE FOR INTENTIONS ABOUT CERVICAL CANCER SCREENING THAN IMPLICIT ATTITUDES
de Vries, M.
P1-23   SUPPORTING PATIENT DECISION-MAKING FOR SURGERY VERSUS PROLONGED CONSERVATIVE TREATMENT FOR HERNIATED DISK: EVALUATION OF ENRICHED VIDEO AND TEXTUAL WEB-BASED PATIENT DECISION AIDS IN A MULTI-CENTER RANDOMIZED TRIAL
de Wit, G. A.
C-1   DON'T USE A LOT WHERE A LITTLE WILL DO: A MINIMAL INFORMATION DECISION-ANALYTIC APPROACH TO EARLY HTA OF DIAGNOSTIC TESTS
Deeks, S.
K-1   THE COST-EFFECTIVENESS OF INTEGRATED CERVICAL CANCER PREVENTION STRATEGIES IN THE ONTARIO SETTING – CAN WE DO BETTER?
Deflin, M.
P4-3   COST EFFECTIVENESS OF A GENE EXPRESSION SCORE AND MYOCARDIAL PERFUSION IMAGING FOR DIAGNOSIS OF CORONARY ARTERY DISEASE
del Mar, C.
P2-31   RCT OF MCDA TO PERSONALISE PREVENTIVE HEALTH DECISIONS
Delahoussaye, A. R.
D-5   NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN
Delaney, B. C.
B-6   A RANDOMIZED CONTROLLED TRIAL OF TWO PRINCIPLES OF DIAGNOSTIC SUPPORT
Delgado, M. K.
TRA2-3   THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE ACCURACY ON THE COST-EFFECTIVENESS HELICOPTER SCENE TRANSPORT FOR TRAUMA
Denton, B. T.
P1-47   OPTIMIZATION OF HYPERGLYCEMIA TREATMENT INTENSIFICATION FOR PATIENTS WITH TYPE 2 DIABETES
Desroches, S.
P2-17   USING THE OPTION INSTRUMENT TO ASSESS THE EXTENT TO WHICH HEALTH PROFESSIONALS INVOLVE PATIENTS IN DECISION MAKING: A SYSTEMATIC REVIEW,
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS,
P2-30   HEALTHCARE PROVIDERS' INTENTIONS TO ENGAGE IN AN INTERPROFESSIONAL APPROACH TO SHARED DECISION MAKING IN HOME CARE PROGRAMS: A MIXED METHODS STUDY
Devine, E. B.
P2-46   AUTOMATING CLINICAL DATA EXTRACTION TO SUPPORT COMPARATIVE EFFECTIVENESS RESEARCH
Dhillon, H.
A-2   WOMEN'S RESPONSES TO INFORMATION ABOUT OVERDIAGNOSIS IN MAMMOGRAPHY SCREENING
Diaz, M. V.
P4-27   INTEGRATING THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) SYMPTOM ASSESSMENT INTO ROUTINE CANCER CARE
Diaz Ordaz, K.
C-2   MULTIPLE IMPUTATION METHODS FOR HANDLING MISSING DATA IN COST-EFFECTIVENESS ANALYSES: AN APPLICATION TO CLUSTER RANDOMISED TRIALS
DiBonaventura, M.
P3-29   PATIENT-REPORTED SATISFACTION ON USTEKINUMAB TREATMENT COMPARED WITH PRIOR BIOLOGIC THERAPY
Dickson, M.
G-1   BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?,
J-2   HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND FIT BETWEEN VALUES AND OPTIONS HELPS PEOPLE MAKE CHOICES CONCORDANT WITH THEIR STATED VALUES
Dickson, R.
P1-7   COST EFFECTIVENESS OF FIRST LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED OR METASTATIC NON SMALL CELL LUNG CANCER,
P2-9   THE COST EFFECTIVENESS OF PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL DISEASE: AN ECONOMIC EVALUATION
Dinan, M. A.
K-4   MULTIFACTORIAL DECISION MAKING FOR CHEMOTHRAPY IN EARLY-STAGE BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF ONCOTYPE DX,
P1-40   NET EFFECT OF CURRENT PATTERNS OF ORAL CONTRACEPTIVE USE ON POTENTIALLY FATAL OUTCOMES IN THE UNITED STATES,
P1-41   USING NET BENEFITS AND ACCEPTABILITY CURVES TO QUANTIFY UNCERTAINTY ABOUT TRADEOFFS BETWEEN HARMS AND BENEFITS OF ORAL CONTRACEPTIVES
Dobbins, T.
P2-31   RCT OF MCDA TO PERSONALISE PREVENTIVE HEALTH DECISIONS
Doble, B. M.
P3-22   ECONOMIC EVALUATIONS OF PERSONALIZED MEDICINE IN ONCOLOGY: WHY ARE THEY SO IMPERSONAL?,
P3-23   SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: IDENTIFYING, SYNTHESIZING AND PRESENTING EVIDENCE TO AID IN TRANSLATION
Doctor, J. N.
P2-13   COST-EFFECTIVENESS ESTIMATES IN A DOUBLY RANDOMIZED PREFERENCE DESIGN,
P3-6   DETERMINING MINIMAL CLINICALLY IMPORTANT DIFFERENCE FOR THE PREFERENCE-BASED INSTRUMENTS EUROQOL (EQ-5D) AND QUALITY OF WELL-BEING (QWB) IN POST-TRAUMATIC STRESS DISORDER (PTSD) PATIENTS,
P4-6   COST-EFFECTIVENESS OF TREATMENT EFFECT AND TREATMENT-PREFERENCE EFFECT OF COGNITIVE BEHAVIORAL THERAPY VERSUS PHARMACOTHERAPY IN POST-TRAUMATIC STRESS DISORDER (PTSD)
Dolan, J. G.
P3-21   THE ADDED BENEFITS OF USING AN INTERACTIVE PATIENT DECISION DASHBOARD,
P3-32   DECISION MODEL FOR DIABETIC RETINOPATHY DETECTION VIA TELEOPHTHALMOLOGY IN A MIGRANT FARM WORKER POPULATION,
P3-44   PT VS TKA: WEIGHING THE PROS AND CONS
Dolovich, L.
P3-53   IMPLEMENTING DECISION BOXES IN PRIMARY HEALTHCARE TEAMS TO FACILITATE SHARED DECISION MAKING: BARRIERS AND FACILITATORS
Domenico, H. J.
TRA2-1   REAL-TIME PREDICTIVE MODELING TO STRATIFY RISK FOR ALL ADULT INPATIENTS TO REDUCE HOSPITAL READMISSIONS
Donkers, B.
P4-36   MEN'S PREFERENCES FOR PROSTATE CANCER SCREENING: A DISCRETE CHOICE EXPERIMENT
Donovan, H. S.
P1-16   WHO INITIATES CANCER SYMPTOM MANAGEMENT DISCUSSIONS? FACTORS ASSOCIATED WITH PATIENT VS. CLINICIAN INITIATION IN WOMEN WITH OVARIAN CANCER
Douglas, P. S.
B-4   REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF EXERCISE TESTING WITH IMAGING FOR CORONARY ARTERY DISEASE,
P4-3   COST EFFECTIVENESS OF A GENE EXPRESSION SCORE AND MYOCARDIAL PERFUSION IMAGING FOR DIAGNOSIS OF CORONARY ARTERY DISEASE
Dowd, B. E.
P1-4   LINEAR REGRESSION METAMODELING AS A TOOL TO SUMMARIZE AND PRESENT SIMULATION MODEL OUTPUTS
Dowie, J.
P2-31   RCT OF MCDA TO PERSONALISE PREVENTIVE HEALTH DECISIONS
Downs, S. M.
G-3   PARENTS' ATTITUDES ABOUT THE USE OF RESIDUAL NEWBORN BLOOD SPOTS FOR RESEARCH
Drew, M. A.
P3-8   FACE-TIME VERSUS TEST ORDERING: IS THERE A TRADE-OFF?,
P4-9   REAL-TIME LOCATION SYSTEMS, NORMATIVE MESSAGING AND CHANGING CLINICIAN BEHAVIOR,
P4-10   IN-GROUP/OUT-GROUP – DOES IT MAKE A DIFFERENCE? GENDER, ETHNICITY, RACE AND FACE-TIME
Drolet, R.
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS
Drummond, M.
AWD1-3   SMDM JOHN M. EISENBERG AWARD FOR PRACTICAL APPLICATION OF MEDICAL DECISION MAKING RESEARCH
Druyts, E.
H-4   WHY THE FINDINGS OF PUBLISHED BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS MULTIPLE TREATMENT COMPARISON META-ANALYSES ARE DIFFERENT: AN OVERVIEW OF RECURRENT METHODOLOGICAL SHORTCOMINGS
Dudley, R. A.
P1-22   INFORMATION-SEEKING BEHAVIOR AND DECISION MAKING IN PATIENTS UNDERGOING ELECTIVE CARDIAC PROCEDURES
Dumont, S.
P2-30   HEALTHCARE PROVIDERS' INTENTIONS TO ENGAGE IN AN INTERPROFESSIONAL APPROACH TO SHARED DECISION MAKING IN HOME CARE PROGRAMS: A MIXED METHODS STUDY
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z